This company has been marked as potentially delisted and may not be actively trading. NASDAQ:IMI Intermolecular (IMI) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Intermolecular Stock (NASDAQ:IMI) 30 days 90 days 365 days Advanced Chart Remove Ads Get Intermolecular alerts:Sign Up Key Stats Today's Range$1.20▼$1.2050-Day Range$1.20▼$1.2052-Week Range$0.88▼$1.25VolumeN/AAverage Volume57,852 shsMarket Capitalization$59.71 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewIntermolecular, Inc. engages in the development of advanced materials using high productivity combinatorial (HPC) technology platform for the semiconductors, consumer electronics, automotive, and aerospace industries worldwide. The company's HPC platform includes Tempus processing tools, automated characterization methods, and informatics analysis software for research and development using combinatorial process systems in concert with established chemical vapor deposition, physical vapor deposition, and atomic layer deposition methods. It serves various markets, including semiconductor, glass, advanced alloys, light-emitting diodes, flat-panel displays, and others. The company was formerly known as The BEP Group, Inc. and changed its name to Intermolecular, Inc. in November 2004. Intermolecular, Inc. was founded in 2004 and is headquartered in San Jose, California.Read More… Remove Ads Receive IMI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Intermolecular and its competitors with MarketBeat's FREE daily newsletter. Email Address IMI Stock News HeadlinesInfinity Mining Ltd IMIMay 24, 2024 | morningstar.comIntegrated Micro-Electronics Inc IMIMay 1, 2024 | morningstar.comTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.April 2, 2025 | Porter & Company (Ad)MSCI EM IMI (MIEF000I0PUS)May 1, 2024 | investing.comAmundi Msci Uk Imi Sri Pab Share Price (C1U.PA)November 25, 2023 | lse.co.ukIMI plc IMINovember 25, 2023 | morningstar.comMorocco earthquake: Watch aftershocks send rescue teams runningSeptember 27, 2023 | bbc.co.ukMSCI ACWI IMI (MIWD000I0PUS)September 24, 2023 | investing.comSee More Headlines IMI Stock Analysis - Frequently Asked Questions How were Intermolecular's earnings last quarter? Intermolecular Inc (NASDAQ:IMI) released its earnings results on Thursday, August, 8th. The semiconductor company reported ($0.11) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.03) by $0.08. The semiconductor company earned $4.62 million during the quarter. Intermolecular had a negative net margin of 42.74% and a negative trailing twelve-month return on equity of 33.13%. What other stocks do shareholders of Intermolecular own? Based on aggregate information from My MarketBeat watchlists, some other companies that Intermolecular investors own include A.H. Belo (AHC), Aerojet Rocketdyne (AJRD), Antares Pharma (ATRS), Genetic Technologies (GENE), CarMax (KMX), Liquidity Services (LQDT) and Orion Energy Systems (OESX). Company Calendar Last Earnings8/08/2019Today4/01/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorComputer and Technology Industry Semiconductors & Related Devices Sub-IndustrySemiconductors Current SymbolNASDAQ:IMI CIK1311241 Webwww.intermolecular.com Phone408-582-5700FaxN/AEmployees88Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-3,410,000.00 Net Margins-42.74% Pretax MarginN/A Return on Equity-33.13% Return on Assets-23.82% Debt Debt-to-Equity Ratio0.43 Current Ratio4.74 Quick Ratio4.74 Sales & Book Value Annual Sales$33.66 million Price / Sales1.77 Cash Flow$0.03 per share Price / Cash Flow45.51 Book Value$0.69 per share Price / Book1.74Miscellaneous Outstanding Shares49,760,000Free FloatN/AMarket Cap$59.71 million OptionableNot Optionable Beta0.93 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.Get This Free Report This page (NASDAQ:IMI) was last updated on 4/2/2025 by MarketBeat.com Staff From Our PartnersDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Intermolecular Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Intermolecular With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.